Consistent self-monitoring in a commercial app-based intervention for weight loss: results from a randomized trial.
Michele L PatelTaylor L BrooksGary G BennettPublished in: Journal of behavioral medicine (2019)
Self-monitoring is the strongest predictor of success in lifestyle interventions for obesity. In this secondary analysis of the GoalTracker trial, we describe outcomes of consistently self-monitoring in a standalone weight loss intervention. The 12-week intervention focused on daily self-monitoring of diet and/or body weight in a commercial app (MyFitnessPal). Participants (N = 100; 21-65 years; BMI 25-45 kg/m2) were categorized as Consistent Trackers if they tracked ≥ 6 out of 7 days for at least 75% of the targeted weeks. One-fourth of participants were Consistent Trackers. This subset was more likely to be married or living with a partner, be non-Hispanic White, and have higher health literacy than Inconsistent Trackers (ps < .05). Consistent tracking was associated with greater weight change than inconsistent tracking at 1 month (mean difference [95% CI] - 1.11 kg [- 2.12, - 0.10]), 3 months (- 2.42 kg [- 3.80, - 1.04]), and 6 months (- 2.13 kg [- 3.99, - 0.27]). Over 3 times as many Consistent Trackers as Inconsistent Trackers achieved ≥ 5% weight loss at 3 months (48 vs. 13%) and at 6 months (54 vs. 15%; ps < .001). Though causality cannot be determined by the present study, tracking weight and/or diet nearly every day per week for 12 weeks in a commercial app may serve as an effective strategy for weight loss. Strategies are needed to promote greater consistency in tracking.
Keyphrases
- weight loss
- bariatric surgery
- roux en y gastric bypass
- randomized controlled trial
- gastric bypass
- body weight
- weight gain
- glycemic control
- physical activity
- obese patients
- study protocol
- healthcare
- clinical trial
- emergency department
- type diabetes
- drug delivery
- insulin resistance
- hepatitis c virus
- cancer therapy
- adverse drug
- human immunodeficiency virus
- skeletal muscle